sodium valproate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
EPILIM IV sodium valproate 400 mg powder for injection vial with diluent ampoule
AUST R: 104416
Active ingredients:
sodium valproate

Dosage form:
Injection, powder for

Sponsor:
Sanofi-Aventis Australia Pty Ltd

Phone:
1800818806

From
11 Nov 2021
to
22 Dec 2021

Shortage status:
Current

Availability:
Emergency Supply Only

Reason:
Unexpected increase in demand due to other sponsors unable to supply

Management action:
An unregistered product has been approved for supply under Section 19A. The Section 19A approval holder, Juno Pharmaceuticals can be contacted on: 03 8888 1288 for further details on supply.

SODIUM VALPROATE JUNO sodium valproate 400 mg/4mL solution for injection, ampoule
AUST R: 281241
Active ingredients:
sodium valproate

Dosage form:
Injection, solution

Sponsor:
Juno Pharmaceuticals Pty Ltd

Phone:
1800 620 076

From
16 Nov 2021
to
01 Jan 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A. The Section 19A approval holder, Juno Pharmaceuticals can be contacted on: 03 8888 1288 for further details on supply.

SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule
AUST R: 279248
Active ingredients:
sodium valproate

Dosage form:
Injection, solution

Sponsor:
Wockhardt Bio Pty Ltd

Phone:
0299766876

From
27 Oct 2021
to
01 Feb 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A. The Section 19A approval holder, Juno Pharmaceuticals can be contacted on: 03 8888 1288 for further details on supply.

VALPREASE 200 sodium valproate 200 mg tablet blister pack
AUST R: 153053
Active ingredients:
sodium valproate

Dosage form:
Tablet, enteric coated

Sponsor:
Arrow Pharma Pty Ltd

Phone:
1800 195 055

From
05 Nov 2021
to
08 Apr 2022

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

VALPREASE 500 sodium valproate 500 mg tablet blister pack
AUST R: 153054
Active ingredients:
sodium valproate

Dosage form:
Tablet, enteric coated

Sponsor:
Arrow Pharma Pty Ltd

Phone:
1800 195 055

From
29 Oct 2021
to
08 Apr 2022

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing